| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Common Stock | 36.8K | $2.58M | $70.03 | 27 Mar 2025 | Direct |
| SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Employee stock option (right to buy) | 110K | 27 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 27 Mar 2025 | 11 | -$794K | 4 | Sr. VP of Clinical Development | 31 Mar 2025, 19:18 |
| SLNO | SOLENO THERAPEUTICS INC | 21 Jan 2025 | 2 | $0 | 4 | Sr. VP of Clinical Development | 23 Jan 2025, 16:25 |
| SLNO | SOLENO THERAPEUTICS INC | 17 Jul 2024 | 1 | $0 | 4 | Sr. VP of Clinical Development | 19 Jul 2024, 09:03 |
| SLNO | SOLENO THERAPEUTICS INC | 22 Apr 2024 | 0 | $0 | 3 | Sr. VP of Clinical Development | 30 Apr 2024, 17:53 |